6 completed, 1 recruiting, 1 terminated. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Pulmonary Fibrosis Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pulmonary Fibrosis Foundation Community Registry Pulmonary Fibrosis, Interstitial Lung Disease | Recruiting | Pulmonary Fibrosis Foundation | 10000 | 2022-07-11 | 2026-09-17 | |
| Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial N-acetyl cysteine, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Completed | Fernando J Martinez | 202 | 2020-12-17 | 2026-03-20 |
| Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis Chronic Hypersensitivity Pneumonitis Health Related Quality of Life Survey Instrument - Hypersensitivity Pneumonitis, Chronic Hypersensitivity Pneumonitis | Completed | Weill Medical College of Cornell University | 60 | 2020-07-10 | 2023-07-27 | |
| Pulmonary Fibrosis Foundation Patient Registry Interstitial Lung Disease (ILD), Idiopathic Pulmonary Fibrosis (IPF) | Completed | Pulmonary Fibrosis Foundation | 2004 | 2016-03-29 | 2023-07-07 | |
| Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis Physical exercise training, Cognitive exercise training - Idiopathic Pulmonary Fibrosis | Not applicable | Completed | University of Alabama at Birmingham | 20 | 2015-08-01 | 2019-02-15 |
| Supplemental Oxygen in Pulmonary Fibrosis Pulmonary Fibrosis | Completed | National Jewish Health | 19 | 2013-10-01 | 2020-02-25 | |
| Pulmonary Fibrosis Contact Registry Pulmonary Fibrosis of Any Cause, Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis | Completed | National Jewish Health | 300 | 2013-08-01 | 2019-03-13 | |
| Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis Sildenafil, Losartan, Sildenafil and Losartan - Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis | Phase 2 / Phase 3 | Terminated | Alicia Gerke | 12 | 2009-09-01 | 2018-11-13 |
Idiopathic Pulmonary Fibrosis (7) · Lung Diseases, Interstitial (5) · Pulmonary Fibrosis (5) · Connective Tissue Diseases (2) · Alveolitis, Extrinsic Allergic (1)
Acetylcysteine (1) · Exercise (1) · Losartan (1) · Sildenafil Citrate (1) · Sugars (1)
United States (8)
Jeff Swigris, DO, MS (2) · Alicia K Gerke, MD (1) · Cathie Spino, ScD (1) · Fernando J Martinez, MD (1) · Hon K Yuen, PhD (1) · Imre Noth, MD (1) · Kerri I Aronson, MD (1) · Kevin Flaherty, MS, MD (1) · Kevin R Flaherty, MD (1) · Tejaswini Kulkarni, MD (1)
PMID 28668090, PMID 29166901, PMID 29169394, PMID 31241519, PMID 36481866, PMID 36514019, PMID 38386005, PMID 42548421
U24HL145265 (1)